IBDEI0VQ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14126,1,3,0)
 ;;=3^Osteoporosis,Age-Related Fx,Unspec Site,Sequela
 ;;^UTILITY(U,$J,358.3,14126,1,4,0)
 ;;=4^M80.00XS
 ;;^UTILITY(U,$J,358.3,14126,2)
 ;;=^5013368
 ;;^UTILITY(U,$J,358.3,14127,0)
 ;;=M81.0^^83^821^126
 ;;^UTILITY(U,$J,358.3,14127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14127,1,3,0)
 ;;=3^Osteoporosis,Age-Related
 ;;^UTILITY(U,$J,358.3,14127,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,14127,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,14128,0)
 ;;=Z87.310^^83^821^137
 ;;^UTILITY(U,$J,358.3,14128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14128,1,3,0)
 ;;=3^Personal Hx of Healed Osteoporosis Fx
 ;;^UTILITY(U,$J,358.3,14128,1,4,0)
 ;;=4^Z87.310
 ;;^UTILITY(U,$J,358.3,14128,2)
 ;;=^5063485
 ;;^UTILITY(U,$J,358.3,14129,0)
 ;;=M81.6^^83^821^133
 ;;^UTILITY(U,$J,358.3,14129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14129,1,3,0)
 ;;=3^Osteoporosis,Localized
 ;;^UTILITY(U,$J,358.3,14129,1,4,0)
 ;;=4^M81.6
 ;;^UTILITY(U,$J,358.3,14129,2)
 ;;=^5013556
 ;;^UTILITY(U,$J,358.3,14130,0)
 ;;=M54.00^^83^821^134
 ;;^UTILITY(U,$J,358.3,14130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14130,1,3,0)
 ;;=3^Panniculitis,Neck/Back,Unspec Site
 ;;^UTILITY(U,$J,358.3,14130,1,4,0)
 ;;=4^M54.00
 ;;^UTILITY(U,$J,358.3,14130,2)
 ;;=^5012285
 ;;^UTILITY(U,$J,358.3,14131,0)
 ;;=M79.3^^83^821^135
 ;;^UTILITY(U,$J,358.3,14131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14131,1,3,0)
 ;;=3^Panniculitis,Unspec
 ;;^UTILITY(U,$J,358.3,14131,1,4,0)
 ;;=4^M79.3
 ;;^UTILITY(U,$J,358.3,14131,2)
 ;;=^5013323
 ;;^UTILITY(U,$J,358.3,14132,0)
 ;;=M62.3^^83^821^136
 ;;^UTILITY(U,$J,358.3,14132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14132,1,3,0)
 ;;=3^Paraplegic Immobility Syndrome
 ;;^UTILITY(U,$J,358.3,14132,1,4,0)
 ;;=4^M62.3
 ;;^UTILITY(U,$J,358.3,14132,2)
 ;;=^5012630
 ;;^UTILITY(U,$J,358.3,14133,0)
 ;;=R29.3^^83^821^139
 ;;^UTILITY(U,$J,358.3,14133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14133,1,3,0)
 ;;=3^Posture,Abnormal
 ;;^UTILITY(U,$J,358.3,14133,1,4,0)
 ;;=4^R29.3
 ;;^UTILITY(U,$J,358.3,14133,2)
 ;;=^322158
 ;;^UTILITY(U,$J,358.3,14134,0)
 ;;=M54.10^^83^821^140
 ;;^UTILITY(U,$J,358.3,14134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14134,1,3,0)
 ;;=3^Radiculopathy,Unspec Site
 ;;^UTILITY(U,$J,358.3,14134,1,4,0)
 ;;=4^M54.10
 ;;^UTILITY(U,$J,358.3,14134,2)
 ;;=^5012295
 ;;^UTILITY(U,$J,358.3,14135,0)
 ;;=M79.5^^83^821^141
 ;;^UTILITY(U,$J,358.3,14135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14135,1,3,0)
 ;;=3^Residual FB in Soft Tissue
 ;;^UTILITY(U,$J,358.3,14135,1,4,0)
 ;;=4^M79.5
 ;;^UTILITY(U,$J,358.3,14135,2)
 ;;=^272608
 ;;^UTILITY(U,$J,358.3,14136,0)
 ;;=M62.82^^83^821^142
 ;;^UTILITY(U,$J,358.3,14136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14136,1,3,0)
 ;;=3^Rhabdomyolysis
 ;;^UTILITY(U,$J,358.3,14136,1,4,0)
 ;;=4^M62.82
 ;;^UTILITY(U,$J,358.3,14136,2)
 ;;=^5012679
 ;;^UTILITY(U,$J,358.3,14137,0)
 ;;=M79.0^^83^821^143
 ;;^UTILITY(U,$J,358.3,14137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14137,1,3,0)
 ;;=3^Rheumatism,Unspec
 ;;^UTILITY(U,$J,358.3,14137,1,4,0)
 ;;=4^M79.0
 ;;^UTILITY(U,$J,358.3,14137,2)
 ;;=^5013320
 ;;^UTILITY(U,$J,358.3,14138,0)
 ;;=M05.9^^83^821^144
 ;;^UTILITY(U,$J,358.3,14138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14138,1,3,0)
 ;;=3^Rheumatoid Arthritis w/ Rheumatoid Factor,Unspec
